Goldman Sachs Neutral Rating on Baxter Stock
Thursday, 30 May 2024, 06:16
Goldman Sachs Sets Baxter Stock at Neutral
Goldman Sachs has recently rated Baxter stock as neutral, indicating potential implications for investors. This new development could have a significant impact on Baxter's market performance.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.